Private Trust Company’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Private Trust Company’s Portfolio BTAL Stock Details BTAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-163	Closed	-$2.6K	–	2562
2025 Q3	$2.6K	Buy	+163	New	+$2.69K	﹤0.01%	2305
2025 Q2	–	Sell	-3,689	Closed	-$76.9K	–	2477
2025 Q1	$76.9K	Buy	+3,689	New	+$69.9K	0.01%	1025
2024 Q4	–	Sell	-201	Closed	-$3.94K	–	2336
2024 Q3	$3.94K	Buy	+201	New	+$4K	﹤0.01%	2023
2024 Q1	–	Sell	-406	Closed	-$6.88K	–	2260
2023 Q4	$6.88K	Buy	+406	New	+$8.07K	﹤0.01%	1803

Other funds holding BTAL

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

CCA

Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Private Trust Company's BTAL Position: Q4 2025 in Review

Private Trust Company sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 163 shares — an estimated $2.6K sold.

Private Trust Company first reported a position in BTAL in Q4 2023 and held it in 4 quarters. The position peaked at $76.9K in Q1 2025. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

Private Trust Company reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
Private Trust Company sold 163 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $2.6K.
Private Trust Company first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and held it in 4 quarters.
Private Trust Company's AGF US Market Neutral Anti-Beta Fund position peaked at $76.9K in Q1 2025.
81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.